Evidence map›Paper›PMID 39724085›Full record

ArticlePloS one2024

Phenotypic and molecular characterization of the largest worldwide cluster of hereditary angioedema type 1.

Juan Sebastian Arias-Flórez, Sandra Ximena Ramirez, Bibiana Bayona-Gomez, Lina Castro-Castillo, Valeria Correa-Martinez, Yasmín Sanchez-Gomez, William Usaquén-Martínez, Lilian Andrea Casas-Vargas, Carlos Eduardo Olmos Olmos, Nora Contreras Bravo and 8 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Juan Sebastian Arias-FlórezDepartment of Morphology, Institute of Human Genetics, Grupo Investigación Genética Clínica UNAL, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Sandra Ximena RamirezDepartment of Internal Medicine, Hospital Universitario Mayor-Mederi, Universidad del Rosario, Bogotá D.C, Colombia.
Bibiana Bayona-GomezDepartment of Pediatrics, La Cardio, and Universidad del Rosario, Bogotá D.C, Colombia.ORCID 0000-0001-5307-9910
Lina Castro-CastilloDepartment of Pediatrics, La Cardio, and Universidad del Rosario, Bogotá D.C, Colombia.
Valeria Correa-MartinezSchool of Medicine, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Yasmín Sanchez-GomezUniversidad de Boyacá, Medisens IPS, Tunja, Colombia.
William Usaquén-MartínezGrupo de Genética de Poblaciones e Identificación, Institute of Human Genetics, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Lilian Andrea Casas-VargasGrupo de Genética de Poblaciones e Identificación, Institute of Human Genetics, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Carlos Eduardo Olmos OlmosSchool of Medicine and Health Sciences, Universidad del Rosario, Bogotá D.C., Colombia.
Nora Contreras BravoSchool of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad del Rosario, Bogotá D.C., Colombia.
Camilo Andres Velandia-PiedrahitaSchool of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad del Rosario, Bogotá D.C., Colombia.ORCID 0000-0002-1747-2173
Adrien MorelSchool of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad del Rosario, Bogotá D.C., Colombia.
Rodrigo Cabrera-PerezSchool of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad del Rosario, Bogotá D.C., Colombia.
Natalia Santiago-TovarSchool of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad del Rosario, Bogotá D.C., Colombia.
Cristian Camilo Gaviria-SabogalSchool of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad del Rosario, Bogotá D.C., Colombia.ORCID 0009-0004-9482-4373
Ingrid Tatyana BernalUniversidad Nacional de Colombia, Bogotá, Colombia.
Dora Janeth Fonseca-MendozaSchool of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad del Rosario, Bogotá D.C., Colombia.
Carlos M RestrepoSchool of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad del Rosario, Bogotá D.C., Colombia.ORCID 0000-0001-6410-0084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary angioedema type 1 (HAE1) is a rare, genetically heterogeneous, and autosomal dominant disease. It is a highly variable, insidious, and potentially life-threatening condition, characterized by sudden local, often asymmetric, and episodic subcutaneous and submucosal swelling, caused by pathogenic molecular variants in the SERPING1 gene, which codes for C1-Inhibitor protein. This study performed the phenotypic and molecular characterization of a HAE1 cluster that includes the largest number of affected worldwide. A geographically HAE1 cluster was found in the northeast Colombian department of Boyaca, which accounts for four unrelated families, with 79 suspected to be affected members. Next-Generation Sequencing (NGS) was performed in 2 out of 4 families (Family 1 and Family 4), identifying the variants c.1420C>T and c.1238T>G, respectively. The latter corresponds to a novel mutation. For Families 2 and 3, the c.1417G>A variant was confirmed by Sanger sequencing. This variant had been previously reported to the patient prior to the beginning of this study. Using deep-learning methods, the structure of the C1-Inhibitor protein, p.Gln474* and p.Met413Arg was predicted, and we propose the molecular mechanism related to the etiology of the disease. Using Sanger sequencing, family segregation analysis was performed on 44 individuals belonging to the families analyzed. The identification of this cluster and its molecular analysis will allow the timely identification of new cases and the establishment of adequate treatment strategies. Our results establish the importance of performing population genetic studies in a multi-cluster region for genetic diseases.

Indexed as

Complement C1 Inhibitor ProteinPedigreePhenotypeAdolescentAdultChildColombiaFemaleHereditary Angioedema Types I and IIHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMutationYoung AdultComplement C1 Inhibitor ProteinSERPING1 protein, human

Identifiers

PMID39724085
PMCPMC11671010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.